LU92174I2 - Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci - Google Patents

Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci

Info

Publication number
LU92174I2
LU92174I2 LU92174C LU92174C LU92174I2 LU 92174 I2 LU92174 I2 LU 92174I2 LU 92174 C LU92174 C LU 92174C LU 92174 C LU92174 C LU 92174C LU 92174 I2 LU92174 I2 LU 92174I2
Authority
LU
Luxembourg
Prior art keywords
hydrate
pharmaceutically acceptable
acceptable salt
zoledronic acid
zoledronic
Prior art date
Application number
LU92174C
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32595500&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92174(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LU92174I2 publication Critical patent/LU92174I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU92174C 2000-06-20 2013-03-22 Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci LU92174I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59713500A 2000-06-20 2000-06-20

Publications (1)

Publication Number Publication Date
LU92174I2 true LU92174I2 (fr) 2013-05-22

Family

ID=32595500

Family Applications (1)

Application Number Title Priority Date Filing Date
LU92174C LU92174I2 (fr) 2000-06-20 2013-03-22 Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci

Country Status (6)

Country Link
EP (1) EP1591122B1 (fr)
DK (1) DK1591122T3 (fr)
LU (1) LU92174I2 (fr)
RU (1) RU2288722C2 (fr)
SI (2) SI1591122T1 (fr)
ZA (1) ZA200210361B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102597149A (zh) * 2009-07-21 2012-07-18 迈兰公司 用于连续制造聚异丁烯基透皮贴剂的工艺
EP3295935B1 (fr) 2009-07-31 2020-07-22 Grünenthal GmbH Procédé de cristallisation et biodisponibilité
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
WO2012071517A2 (fr) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Nouvelles formes cristallines
WO2017208070A1 (fr) 2016-05-31 2017-12-07 Grünenthal GmbH Acide bisphosphonique et coformeurs avec lysine, glycine, nicotinamide pour le traitement de la polyarthrite psoriasique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3776880D1 (de) 1986-11-21 1992-04-02 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
IT1296495B1 (it) * 1997-11-21 1999-06-25 Prodotti Antibiotici Spa Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
WO2000071104A2 (fr) * 1999-05-21 2000-11-30 Novartis Ag Compositions pharmaceutiques et leurs utilisations

Also Published As

Publication number Publication date
RU2288722C2 (ru) 2006-12-10
SI1296689T1 (sl) 2006-08-31
EP1591122B1 (fr) 2012-09-26
DK1591122T3 (da) 2013-02-25
SI1591122T1 (sl) 2013-02-28
EP1591122A1 (fr) 2005-11-02
ZA200210361B (en) 2003-11-13

Similar Documents

Publication Publication Date Title
LU92174I2 (fr) Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci
LU92397I2 (fr) Vortioxétine ou un sel d'addition d'acide de celui-ci pharmaceutiquement acceptable
NO20032487D0 (no) Fjernt fuktighetssystem
DE10085137T1 (de) Chirurgischer Sensor
DE60126038D1 (de) Chirurgisches Ultraschallsystem
DE69909135D1 (de) Orale zubereitung zur bekämpfung von mundgeruch
DE60043793D1 (de) Dreidimensionales lenkbares System
DK1335678T3 (da) Oralt behandlingssystem
DE60024273D1 (de) Chirurgische zugangsvorrichtung
DE60204196D1 (de) Endoskopisches System
DE60125769D1 (de) Verbessertes elektroentionisierungssystem
NO20030422D0 (no) Vaginal avlevering av bisfosfonater
DE60140462D1 (de) Darreichungsform zur hormonalen kontrazeption
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
FR2802447B1 (fr) Systeme vaporisateur rechargeable
DE60103889D1 (de) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidderivate zur schmerzbekämpfung
NO20013213L (no) Sonarsystem for bestemmelse av fiskestorrelse
DE60117207D1 (de) Gerät zur Verwaltung des weiblichen physischen Zustands
EE200300294A (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
DK1031288T3 (da) Mælkemineralpræparat
FR2810511B1 (fr) Chausson lavable pour article chaussant
ATE289603T1 (de) Chinolinyl-piperidin-4-yliden-methyl-benzamid- derivate zur schmerzbekämpfung
DE60117330D1 (de) Gerät zur Verwaltung des weiblichen physischen Zustands
DE50005386D1 (de) Aminophosphoniumverbindungen
DE60143769D1 (de) Elektronisch geregeltes Bremssystem